Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
第一作者:
David,Malka
第一单位:
Institut Gustave Roussy, Villejuif, Université Paris Sud, Paris, France. Electronic address: david.malka@gustaveroussy.fr.
作者:
医学主题词
成年人(Adult);老年人(Aged);丙氨酸转氨酶(Alanine Transaminase);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);天冬氨酸氨基转移酶类(Aspartate Aminotransferases);胆管肿瘤(Bile Duct Neoplasms);胆管, 肝内(Bile Ducts, Intrahepatic);癌(Carcinoma);胆管上皮癌(Cholangiocarcinoma);胆总管肿瘤(Common Bile Duct Neoplasms);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);女(雌)性(Female);胆囊肿瘤(Gallbladder Neoplasms);人类(Humans);意向治疗分析(Intention to Treat Analysis);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);中性粒细胞减少(Neutropenia);有机铂化合物(Organoplatinum Compounds);周围神经系统疾病(Peripheral Nervous System Diseases);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));ras蛋白质类(ras Proteins)
DOI
10.1016/S1470-2045(14)70212-8
PMID
24852116
发布时间
2025-05-29
- 浏览75
The Lancet. Oncology
819-28页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



